The Ensign Group (NASDAQ:ENSG) Stock: Insider Mark Vincent Parkinson Sells 100 Shares

The Ensign Group, Inc. (NASDAQ:ENSG) Director Mark Parkinson sold 100 shares of the stock in a transaction on Friday, October 16th. The stock was sold at an average price of $179.62, for a total value of $17,962.00. Following the sale, the director owned 4,400 shares of the company’s stock, valued at approximately $790,328. This represents a 2.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

The Ensign Group Price Performance

ENSG opened at $176.00 on Wednesday. The stock has a market cap of $10.26 billion, a price-to-earnings ratio of 27.59, a PEG ratio of 1.64 and a beta of 0.66. The Ensign Group, Inc. has a 1 year low of $141.58 and a 1 year high of $218.00. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.06. The stock has a fifty day moving average price of $175.12 and a 200 day moving average price of $175.05.

The Ensign Group (NASDAQ:ENSG) last issued its earnings results on Monday, July 27th. The company reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.12. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%. The firm had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the previous year, the company posted $1.59 earnings per share. The business’s quarterly revenue was up 16.7% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Analysts forecast that The Ensign Group, Inc. will post 7.04 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Saturday, October 31st. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.0650 per share. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date is Wednesday, September 30th. The Ensign Group’s payout ratio is currently 4.08%.

More The Ensign Group News

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Ensign’s latest reported quarter provided fundamental support: earnings per share exceeded expectations, revenue increased 16.7% year over year to $1.44 billion, and fiscal 2026 EPS guidance is $7.75–$7.85. Analysts maintain a generally favorable view, with a consensus “Moderate Buy” rating and an average price target of $216.25. The Ensign Group analysis
• Neutral Sentiment: Director Mark Parkinson sold 100 shares for approximately $17,962 under a pre-arranged Rule 10b5-1 trading plan. The sale reduced his position by 2.22%, but he continues to own 4,400 shares, limiting its significance as a bearish signal. SEC insider transaction filing
• Negative Sentiment: Rosen Law Firm and other firms announced or promoted a securities class action covering investors who purchased Ensign securities from February 10, 2022, through June 18, 2026. Investors seeking lead-plaintiff status must act by December 7, 2026. Rosen class action announcement
• Negative Sentiment: The complaint reportedly alleges that Ensign concealed patient neglect, understaffing, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme. Repeated notices from Glancy Prongay Wolke & Rotter, Kaplan Fox, Bleichmar Fonti & Auld, Moore Law and others are increasing visibility around potential legal costs, damages and reputational risk. These remain allegations, not established findings. Ensign securities-fraud lawsuit report

Analysts Set New Price Targets

A number of research firms recently commented on ENSG. Weiss Ratings upgraded The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Wall Street Zen lowered shares of The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday. Royal Bank Of Canada reiterated an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a research note on Tuesday, July 28th. Finally, Truist Financial boosted their target price on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a research report on Thursday, July 30th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $216.25.

Hedge Funds Weigh In On The Ensign Group

Several hedge funds have recently bought and sold shares of the business. Dockside LLC acquired a new position in The Ensign Group during the second quarter valued at approximately $2,180,000. Wasatch Advisors LP raised its position in shares of The Ensign Group by 10.7% in the second quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company’s stock valued at $365,215,000 after purchasing an additional 220,329 shares during the period. Oppenheimer Asset Management Inc. acquired a new stake in shares of The Ensign Group in the second quarter worth $8,619,000. Nykredit A S acquired a new stake in shares of The Ensign Group in the second quarter worth $462,000. Finally, NewEdge Wealth LLC acquired a new stake in shares of The Ensign Group in the second quarter worth $8,518,000. 96.12% of the stock is owned by institutional investors and hedge funds.

About The Ensign Group

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.